Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of KD-332 versus DTaP + live oral polio vaccine in healthy children
jRCT2080221042Phase 3
- Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Start
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Quattrovac in diphtheria, Tetanus, pertussis and 1 more (2 arms), sponsored by The Chemo-Sero-Therapeutic Research Institute.
02
Drugs
Quattrovac
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on jRCT2080221042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221042.